Referensi Tuberkulosis M

1. Ma, J.J., Guo, Y.J., Li, Z., Chen, Y., He, H. and Li, W.M., 2022. Prevalence and prognostic significance of malnutrition risk in patients with pulmonary tuberculosis: a hospital-based cohort study. Frontiers in Public Health, 10, p.1039661.
2. Macpherson L, Kik SV, Quartagno M, Lakay F, Jaftha M, Yende N, Galant S, Aziz S, Daroowala R, Court R, Taliep A. Diagnostic accuracy of chest X-ray computer-aided detection software for detection of prevalent and incident tuberculosis in household contacts. Clinical Infectious Diseases. 2025 Mar 15;80(3):626-36.
3. Madaki, S., Mohammed, Y., Rogo, L.D., Yusuf, M. and Bala, Y.G., 2024. Age and gender in drug resistance tuberculosis: a cross-sectional case study at a national tuberculosis reference hospital in Nigeria. Journal of Global Antimicrobial Resistance, 39, pp.175-183.
4. Mafirakureva, N., Cartledge, A., Bradshaw, I., Bekker, A., Salazar-Austin, N., Meehan, S.A., Myer, L., Odayar, J., Rangaka, M.X. and Dodd, P.J., 2026. Global estimates of tuberculosis incidence during pregnancy and postpartum: a rapid review and modelling analysis. The Lancet Global Health.
5. Magee, M.J., Salindri, A.D., Gujral, U.P., Auld, S.C., Bao, J., Haw, J.S., Lin, H.H. and Kornfeld, H., 2018. Convergence of non-communicable diseases and tuberculosis: a two-way street?. The International Journal of Tuberculosis and Lung Disease, 22(11), pp.1258-1268.
6. Magee, M.J., Trost, S.L., Salindri, A.D., Amere, G., Day, C.L. and Gandhi, N.R., 2020. Adults with Mycobacterium tuberculosis infection and pre-diabetes have increased levels of QuantiFERON interferon-gamma responses. Tuberculosis, 122, p.101935.
7. Magodoro, I., Kotze, L., Stek, C.J., West, A., Le Roux, A., Sobratee, N., Taliep, A., Hamada, Y., Dave, J.A., Rangaka, M.X. and Parihar, S.P., 2025. Clinical, metabolic and immune interaction between tuberculosis and diabetes mellitus: implications and opportunities for therapies. Expert Opinion on Pharmacotherapy.
8. Magodoro, I.M., Aluoch, A., Claggett, B., Nyirenda, M.J., Siedner, M.J., Wilkinson, K.A., Wilkinson, R.J. and Ntusi, N.A., 2024, October. Association Between Mycobacterium tuberculosis Sensitization and Insulin Resistance Among US Adults Screened for Type 2 Diabetes Mellitus. In Open Forum Infectious Diseases (Vol. 11, No. 10, p. ofae568). US: Oxford University Press.
9. Majaliwa, E.S., Muze, K., Godfrey, E., Byashalira, K., Mmbaga, B.T., Ramaiya, K. and Mfinanga, S.G., 2023. Latent tuberculosis in children and youth with type 1 diabetes mellitus in Dar es Salaam, Tanzania: a cross section survey. BMC Infectious Diseases, 23(1), p.740.
10. Makrufardi, F., Chuang, H.C., Suk, C.W., Lin, Y.C., Rusmawatiningtyas, D., Murni, I.K., Arguni, E., Chung, K.F. and Bai, K.J., 2024. Particulate matter deposition and its impact on tuberculosis severity: A cross-sectional study in Taipei. Science of the Total Environment, 924, p.171534.
11. Mandal, S., Bhatia, V., Bhargava, A., Rijal, S. and Arinaminpathy, N., 2024. The potential impact on tuberculosis of interventions to reduce undernutrition in the WHO South-East Asian Region: a modelling analysis. The Lancet Regional Health-Southeast Asia, p.100423.
12. Mangamba, L.M.E., Halle, M.P., Onana, C.L.M., Tochie, J.N., Ngamby, V., Noubibou, J.C.E., Balkissou, A.D., Tewaffeu, D.G., & Ngahane, B.H.M. (2023). Impact of Chronic Kidney Disease on the Mortality of Tuberculosis Patients: A Cross-Sectional Study in Douala. Health Sciences and Disease, 24(2).
13. Manjourides, J., Lin, H.H., Shin, S., Jeffery, C., Contreras, C., Santa Cruz, J., Jave, O., Yagui, M., Asencios, L., Pagano, M. and Cohen, T., 2012. Identifying multidrug resistant tuberculosis transmission hotspots using routinely collected data. Tuberculosis, 92(3), pp.273-279.
14. Mao, J.J., Zang, X., Yue, W.L., Zhai, P.Y., Zhang, Q., Li, C.H., Zhuang, X., Liu, M. and Qin, G., 2023. Population-level health and economic impacts of introducing Vaccae vaccination in China: a modelling study. BMJ global health, 8(5), p.e012306.
15. Marme, G., Kuzma, J., Zimmerman, P.A., Harris, N. and Rutherford, S., 2024. Investigating socio-ecological factors influencing implementation of tuberculosis infection prevention and control in rural Papua New Guinea. Journal of Public Health, 46(2), pp.267-276.
16. Martinez, L., Zhu, L., Castellanos, M.E., Liu, Q., Chen, C., Hallowell, B.D. and Whalen, C.C., 2017. Glycemic control and the prevalence of tuberculosis infection: a population-based observational study. Clinical Infectious Diseases, 65(12), pp.2060-2068.
17. Matteelli, A., Churchyard, G., Cirillo, D., den Boon, S., Falzon, D., Hamada, Y., Houben, R.M., Kanchar, A., Kritski, A., Kumar, B. and Miller, C., 2024. Optimizing the cascade of prevention to protect people from tuberculosis: A potential game changer for reducing global tuberculosis incidence. PLOS Global Public Health, 4(7), p.e0003306.
18. McCreesh N, MacPherson P, Bampi JV, Engel N, Kranzer K, Khan PY. Reported tuberculosis symptoms: an inadequate classifier of disease state. Clinical Infectious Diseases. 2026 Mar 15;82(3):e589-94.
19. McQuaid, C.F., Clark, R.A., White, R.G., Bakker, R., Alexander, P., Henry, R., Velayutham, B., Muniyandi, M., Sinha, P., Bhargava, M. and Bhargava, A., 2025. Estimating the epidemiological and economic impact of providing nutritional care for tuberculosis-affected households across India: a modelling study. The Lancet Global Health.
20. Medina-Marino A, Arua E, de Vos L, Fiphaza K, Bezuidenhout D, Ngcelwane N, Charalambous S, Daniels J. Hidden in Success: Gendered Patterns of Suboptimal Care Engagement Among Tuberculosis Patients Who “Successfully” Completed Treatment in South Africa. Clinical Infectious Diseases. 2025 Dec 19:ciaf714.
21. Meghji, J., Kon, O.M. and Ainley, A., 2023. Clinical tuberculosis. Medicine, 51(11), pp.768-773.
22. Mendelsohn, S.C., Fiore-Gartland, A., Awany, D., Mulenga, H., Mbandi, S.K., Tameris, M., Walzl, G., Naidoo, K., Churchyard, G., Scriba, T.J. and Hatherill, M., 2022. Clinical predictors of pulmonary tuberculosis among South African adults with HIV. EClinicalMedicine, 45.
23. Meng F, Lan L, Wu G, Ren X, Yuan X,Yang M, Chen Q, Peng X and Liu D (2023). Impact of diabetes itself and glycemic control status on tuberculosis. Front. Endocrinol. 14:1250001.
24. Menzies, N.A., Cohen, T., Lin, H.H., Murray, M. and Salomon, J.A., 2012. Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation. PLoS medicine, 9(11), p.e1001347.
25. Menzies, N.A., Gomez, G.B., Bozzani, F., Chatterjee, S., Foster, N., Baena, I.G., Laurence, Y.V., Qiang, S., Siroka, A., Sweeney, S. and Verguet, S., 2016. Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models. The Lancet global health, 4(11), pp.e816-e826.
26. Menzies, N.A., Brown, T.S., Imai-Eaton, J.W., Dodd, P.J., Cohen, T. and Martinez, L., 2025. Potential paediatric tuberculosis incidence and deaths resulting from interruption in programmes supported by international health aid, 2025–34: a mathematical modelling study. The Lancet Child & Adolescent Health, 9(11), pp.787-795.
27. Migliori GB, Ong CWM, Petrone L, et al. The definition of tuberculosis infection based on the spectrum of tuberculosis disease. Breathe 2021; 17: 210079.
28. Min, J., Jeong, Y., Kim, H.W. and Kim, J.S., 2024. Tuberculosis notification and incidence: Republic of Korea, 2022. Tuberculosis and Respiratory Diseases, 87(3), p.411.
29. Miyoshi, S., Semba, M., Tanabe, M., Sato, C., Watanabe, A., Ito, R., Kubota, M. and Abe, M., 2025. Assessment of Risk Factors for Death in Older Adult Patients With TB in Japan. CHEST Pulmonary, 3(2).
30. Motta, I., Boeree, M., Chesov, D., Dheda, K., Günther, G., Horsburgh Jr, C.R., Kherabi, Y., Lange, C., Lienhardt, C., McIlleron, H.M. and Paton, N.I., 2024. Recent advances in the treatment of tuberculosis. Clinical Microbiology and Infection, 30(9), pp.1107-1114.
31. Mulaku, M.N., Ochodo, E., Young, T. and Steingart, K.R., 2024. Pre-treatment loss to follow-up in adults with pulmonary TB in Kenya. Public Health Action, 14(1), pp.34-39.
32. Mulenga H, Shenje J, Mendelsohn SC, Luabeya AK, Tameris M, Tredoux EN, Nemes E, Bilek N, Beyers E, Ivacik-Goncalves D, Andrews JR. Asymptomatic tuberculosis in children with household exposure to Mycobacterium tuberculosis. Clinical Infectious Diseases. 2026 May 15;82(5):e1005-13.
33. Munir, M.A., Khan, S., Rehman, S., Ahmed, D. and Jabbar, A., 2024. Tuberculosis among diabetes patients: a review of epidemiology, pathophysiology, clinical manifestations, and management. Chronicles of Biomedical Sciences, 1(3), pp.PID26-PID26.
34. Murray, M., Oxlade, O. and Lin, H.H., 2011. Modeling social, environmental and biological determinants of tuberculosis. The International Journal of Tuberculosis and Lung Disease, 15(6), pp.S64-S70.
35. Murrill, M.T., Salcedo, K., Tschampl, C.A., Ahamed, N., Coates, E.S., Flood, J., Wegener, D.H. and Shete, P.B., 2025. Policy Impediments to Tuberculosis Elimination: Consequences of an Absent Medicare National Coverage Determination for Tuberculosis Prevention. Journal of Immigrant and Minority Health, pp.1-6.

Referensi Tuberkulosis N-Q

1. Nabi, S.G., Aziz, M.M., Uddin, M.R., Tuhin, R.A., Shuchi, R.R., Nusreen, N., Jahan, R., Afroz, F. and Islam, M.S., 2024. Nutritional status and other associated factors of patients with tuberculosis in selected urban areas of Bangladesh. Well Testing Journal, 33(S2), pp.571-590.
2. Nalugwa T, Shah KM, Marcelo D, Nakawunde R, Trinh T, Emmanuel J, Nakaweesa A, Schraufnagel A, Andama A, Christopher DJ, Van Luong D. Predicted Preferences for Tuberculosis Point-of-Care Tests among Tuberculosis-Affected Individuals in Five High Burden Countries. Clinical Infectious Diseases. 2026 Jan 14:ciag022.
3. Ngo, M.D.; Bartlett, S.; Ronacher, K. Diabetes-Associated Susceptibility to Tuberculosis: Contribution of Hyperglycemia vs. Dyslipidemia. Microorganisms 2021, 9, 2282.
4. Nguyen, T.A., Teo, A.K.J., Zhao, Y., Quelapio, M., Hill, J., Morishita, F., Marais, B.J. and Marks, G.B., 2024. Population-wide active case finding as a strategy to end TB. The Lancet regional health. Western Pacific, 46, p.101047.
5. Njelita, I.A., Nwachukwu, C.C., Eyisi, I.G., Ezenyeaku, C.A. and Okeke, H.N., 2025. Prevalence and risk factors of active tuberculosis disease in contacts of tuberculosis cases treated in a teaching hospital in southeast Nigeria: a cross-sectional study. International Journal of Healthcare Sciences, 13(1), pp.80-89.
6. Njiro, B.J., Kisonga, R., Joachim, C., Sililo, G.A., Nkiligi, E., Ibisomi, L., Chirwa, T. and Francis, J.M., 2024. Epidemiology and treatment outcomes of recurrent tuberculosis in Tanzania from 2018 to 2021 using the National TB dataset. PLOS Neglected Tropical Diseases, 18(2), p.e0011968.
7. Noviyani, A., Nopsopon, T. and Pongpirul, K., 2021. Variation of tuberculosis prevalence across diagnostic approaches and geographical areas of Indonesia. PLoS One, 16(10), p.e0258809.
8. Nugrahaeni, D.K., Kusumasari, I., Budiana, T.A., and Mauliku, N.E. (2025). Factors Associated with Tuberculosis-Diabetes Mellitus Comorbidity. Periodic Epidemiology Journal/Jurnal Berkala Epidemiologi, 13(1):75-84.
9. Nuraisyah, F., Juliana, N., Astaria, D., Khalisah, N., Al Fatih, D.M.F., Dewi, S.K. and Marwati, T., 2024. Risk Factors of Pulmonary Tuberculosis in Type 2 Diabetes Mellitus in Yogyakarta. Journal of Epidemiology and Public Health, 9(2), pp.194-203.
10. Nwokoye, N., Odume, B., Nwadike, P., Anaedobe, I., Mangoro, Z., Umoren, M., Ogbudebe, C., Chukwuogo, O., Useni, S., Nongo, D. and Eneogu, R., 2024. Impact of the stool-based Xpert test on childhood tuberculosis diagnosis in selected states in Nigeria. Tropical Medicine and Infectious Disease, 9(5), p.100.
11. Ockenga, J., Fuhse, K., Chatterjee, S., Malykh, R., Rippin, H., Pirlich, M., Yedilbayev, A., Wickramasinghe, K. and Barazzoni, R., 2023. Tuberculosis and malnutrition: the European perspective. Clinical Nutrition, 42(4), pp.486-492.
12. Oliveira Hashiguchi, L., Cox, S.E., Edwards, T. et al. How can tuberculosis services better support patients with a diabetes co-morbidity? A mixed methods study in the Philippines. BMC Health Serv Res 23, 1027 (2023). https://doi.org/10.1186/s12913-023-10015-7.
13. Oliveira Hashiguchi, L., Ferrer, J.P., Suzuki, S., Faguer, B.N., Solon, J.A., Castro, M.C., et al. (2024). Glycemic control during TB treatment among Filipinos: The Starting Anti-Tuberculosis Treatment Cohort Study. PLOS Global Public Health, 4(5), e0003156. 
14. Omar, N., Wong, J., Thu, K., Alikhan, M.F. and Chaw, L., 2021. Prevalence and associated factors of diabetes mellitus among tuberculosis patients in Brunei Darussalam: a 6-year retrospective cohort study. International Journal of Infectious Diseases, 105, pp.267-273.
15. Oxlade, O., Benedetti, A., Adjobimey, M., Alsdurf, H., Anagonou, S., Cook, V.J., Fisher, D., Fox, G.J., Fregonese, F., Hadisoemarto, P. and Hill, P.C., 2021. Effectiveness and cost-effectiveness of a health systems intervention for latent tuberculosis infection management (ACT4): a cluster-randomised trial. The Lancet Public Health, 6(5), pp.e272-e282.
16. Pan, S.C., Ku, C.C., Kao, D., Ezzati, M., Fang, C.T. and Lin, H.H., 2015. Effect of diabetes on tuberculosis control in 13 countries with high tuberculosis: a modelling study. The lancet Diabetes & endocrinology, 3(5), pp.323-330.
17. Pan S-C, Chen Y-C, Wang J-Y, Sheng W-H, Lin H-H, Fang C-T, et al. (2015) Tuberculosis in Healthcare Workers: A Matched Cohort Study in Taiwan. PLoS ONE 10(12): e0145047.
18. Pan, S.C., Chen, C.C., Chiang, Y.T., Chang, H.Y., Fang, C.T. and Lin, H.H., 2016. Health care visits as a risk factor for tuberculosis in Taiwan: a population-based case–control study. American journal of public health, 106(7), pp.1323-1328.
19. Pando, C., Hazel, A., Tsang, L.Y., Razafindrina, K., Andriamiadanarivo, A., Rabetombosoa, R.M., Ambinintsoa, I., Sadananda, G., Small, P.M., Knoblauch, A.M. and Rakotosamimanana, N., 2023. A social network analysis model approach to understand tuberculosis transmission in remote rural Madagascar. BMC Public Health, 23(1), p.1511.
20. Pardeshi, G., Mave, V., Gaikwad, S., Kadam, D., Barthwal, M., Gupte, N., Atre, S., Deshmukh, S., Golub, J.E. and Gupte, A., 2024. Glycated Hemoglobin Trajectories and Their Association With Treatment Outcomes Among Patients With Pulmonary TB in India: A Prospective Cohort Study. Chest, 165(2), pp.278-287.
21. Park, S.W., Shin, J.W., Kim, J.Y., Park, I.W., Choi, B.W., Choi, J.C. and Kim, Y.S., 2012. The effect of diabetic control status on the clinical features of pulmonary tuberculosis. European journal of clinical microbiology & infectious diseases, 31, pp.1305-1310.
22. Park, S., Lee, S., Kim, Y., Lee, Y., Kang, M.W., Cho, S., Han, K., Han, S.S., Lee, H., Lee, J.P. and Joo, K.W., 2019. Association of CKD with incident tuberculosis. Clinical Journal of the American Society of Nephrology, 14(7), pp.1002-1010.
23. Patel, D.G., Baral, T., Kurian, S.J., Malakapogu, P., Saravu, K. and Miraj, S.S., 2024. Nutritional status in patients with tuberculosis and diabetes mellitus: A comparative observational study. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 35, p.100428.
24. Peng, Y.F., 2023. Pulmonary tuberculosis and diabetes mellitus: Epidemiology, pathogenesis and therapeutic management. Medicine International, 4(1), p.1-4.
25. Penyami, Y., Angkasa, M.P. and Sumarni, S., 2025. Using storybooks to enhance health awareness among schoolchildren at risk of tuberculosis. Malahayati International Journal of Nursing and Health Science, 7(11), pp.1338-1343.
26. Petruccioli, E., Scriba, T.J., Petrone, L., Hatherill, M., Cirillo, D.M., Joosten, S.A., Ottenhoff, T.H., Denkinger, C.M. and Goletti, D., 2016. Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis. European Respiratory Journal, 48(6), pp.1751-1763.
27. Pradana, T.L.C., Putra, B.T.W. and Utami, W.S., 2025. Stigma Tuberkulosis Paru di Asia Tenggara: Systematic Literatur Review. MAHESA: Malahayati Health Student Journal, 5(6), pp.2501-2512.
28. Pramono, J.S., Ridwan, A., Maria, I.L., Syam, A., Russeng, S.S. and Mumang, A.A., 2024. Active case finding for tuberculosis in migrants: a systematic review. Medical Archives, 78(1), p.60.
29. Pratiwi, R.D., Alisjahbana, B., Subronto, Y.W., Priyanta, S. and Suharna, S., 2025. Implementation of an information system for tuberculosis in healthcare facilities in Indonesia: evaluation of its effectiveness and challenges. Archives of Public Health, 83(1), pp.1-18.
30. Puyat, J.H., Brode, S.K., Shulha, H., Romanowski, K., Menzies, D., Benedetti, A., Duchen, R., Huang, A., Fang, J., Macdonald, L. and Marras, T.K., 2025. Predicting Risk of Tuberculosis (TB) Disease in People Who Migrate to a Low-TB Incidence Country: Development and Validation of a Multivariable, Dynamic Risk-Prediction Model Using Health Administrative Data. Clinical Infectious Diseases, 80(3), pp.644-652.
31. Qi, M., Qiao, R. and He, J.Q., 2025. The association between triglyceride-glucose index and related parameters and risk of tuberculosis infection in American adults under different glucose metabolic states: a cross-sectional study. BMC Public Health, 25(1), pp.1-11.
32. Qi, X., Yang, Q., Cai, J., Wu, J., Gao, Y., Ruan, Q., Shao, L., Liu, J., Zhou, X., Zhang, W. and Jiang, N., 2024. Transcriptional profiling of human peripheral blood mononuclear cells in household contacts of pulmonary tuberculosis patients provides insights into mechanisms of Mycobacterium tuberculosis control and elimination. Emerging Microbes & Infections, 13(1), p.2295387.

Referensi Tuberkulosis G-I

1. Galán, M.D.M.D., Redondo-Bravo, L., Gómez-Barroso, D., Herrera, L., Amillategui, R., Gómez-Castellá, J. and Herrador, Z., 2024. The impact of meteorological factors on tuberculosis incidence in Spain: a spatiotemporal analysis. Epidemiology & Infection, 152, p.e58.
2. Galib, R.K., Paul, S.K., Akter, K., Musa, M.I., Sarker, D.J., Choudhury, S.A.R.A., Paul, S.C. and Chakrabortty, R., 2025. Frequency of Lower Lung Field Tuberculosis in Diabetes Mellitus Patients Attending Tertiary Care Hospital in Bangladesh: A Cross‐Sectional Study. Health Science Reports, 8(1), p.e70413.
3. Gebreweld, A., Fiseha, T., Kebede, E., Tamir, Z., Gebremariam, B., Miruts, F. and Haileslasie, H., 2024. Immuno-Hematological and Biochemical Changes in Patients with Tuberculosis in Dessie Comprehensive Specialized Hospital, Dessie, Ethiopia. Journal of Blood Medicine, pp.147-155.
4. Ginting AA, Pakpahan RE, Zebua SE. Gambaran Kepatuhan Minum Obat Penderita Tuberkulosis Paru Di Rumah Sakit Khusus Paru Medan Sumatera Utara. INNOVATIVE: Journal Of Social Science Research. 2024 Oct 17;4(5):7819-33.
5. Giridharan, P., Suseela, R.P., Zangpo, T., Joshi, R.B., Cader, M., Isbaniah, F., Velayudham, B., Rafeeg, F.N., da Cruz Santos, A., Shah, N.P. and Mathew, M., 2024. Tuberculosis preventive treatment in eight SEAR countries–Current practices, implementation challenges and operations research priorities. Public Health in Practice, 8, p.100518.
6. Godoy, S., Parrón, I., Millet, J.P., Caylà, J.A., Follia, N., Carol, M., Orcau, A., Alsedà, M., Toledo, D., Plans, P. and Ferrús, G., 2024. Risk of tuberculosis among pulmonary tuberculosis contacts: the importance of time of exposure to index cases. Annals of Epidemiology, 91, pp.12-17.
7. Goletti, D., Pisapia, R., Fusco, F.M., Aiello, A. and Van Crevel, R., 2023. Epidemiology, pathogenesis, clinical presentation and management of TB in patients with HIV and diabetes. The International Journal of Tuberculosis and Lung Disease, 27(4), pp.284-290.
8. Guillén, S.M., et al., 2023. Tuberculosis in Spain: An opinion paper. Rev Esp Quimioter, 36(6), pp.562-583.
9. Gupta-Wright, Ankur, Huy Ha, Shima Abdulgadar, Rebecca Crowder, Jerusha Emmanuel, Job Mukwatamundu, Danaida Marcelo et al. "Evaluation of the Xpert MTB Host Response assay for the triage of patients with presumed pulmonary tuberculosis: a prospective diagnostic accuracy study in Viet Nam, India, the Philippines, Uganda, and South Africa." The Lancet Global Health 12, no. 2 (2024): e226-e234.
10. Gurumurthy, M., Gopalan, N., Patel, L., Davis, A., Srinivasalu, V.A., Rajaram, S., Goodall, R., Bronson, G. and STREAM Trial Collaboration, 2025. Treatment outcomes in people with diabetes and multidrug-resistant tuberculosis (MDR TB) enrolled in the STREAM clinical trial. PLOS Global Public Health, 5(4), p.e0004259.
11. Habib, M.A., Afrin, K., Efa, S.S., Hossain, M.D., Islam, M.R., Rahman, M.M., Islam, N., Afroz, F., Rahim, M.A. and Hossain, M.D., 2024. Effects of diabetes mellitus on retreatment of Tuberculosis: A multi-centered case-control study from Bangladesh. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 36, p.100450.
12. Hakam, M.A., Safitri, B.D., Wandastuti, A.D., Husni, M.F., Setiawan, A.W., Konoralma, A.R., Radja, B.L., Setiono, O. and Wulan, W.R., 2024. The Relationship Between Adequate Housing And Household Sanitation With The Success Of Tuberculosis Patient Treatment In Semarang City. International Journal of Health Literacy and Science, 2(2), pp.14-19.
13. Hamada, Y., Quartagno, M., Law, I., Malik, F., Bonsu, F.A., Adetifa, I.M., Adusi-Poku, Y., D'Alessandro, U., Bashorun, A.O., Begum, V. and Lolong, D.B., 2023. Association of diabetes, smoking, and alcohol use with subclinical-to-symptomatic spectrum of tuberculosis in 16 countries: an individual participant data meta-analysis of national tuberculosis prevalence surveys. EClinicalMedicine, 63.
14. Hamada, Y., Lugendo, A., Ntshiqa, T., Kubeka, G., Lalashowi, J.M., Mwastaula, S., Ntshamane, K., Sabi, I., Wilson, S., Copas, A. and Velen, K., 2024. A pilot cross-sectional study of non-communicable diseases in TB household contacts. IJTLD OPEN, 1(4), pp.154-159.
15. Hamsaveni, G., Amrutha, A.M., Sidenur, B., Mangasuli, V. and Vijeth, S.B., 2024. Assessment of quality of life and social correlates among drug sensitive and multidrug-resistant tuberculosis patients. Journal of Association of Pulmonologist of Tamil Nadu, 7(3), pp.100-104.
16. Handayani S, Isworo S, Hinchcliff R, Wahyudi F, Aryani L, Triyono A. Understanding delayed diagnosis and treatment of tuberculosis: a cross-sectional study in Semarang, Indonesia. The Journal of Infection in Developing Countries. 2026 Jan 31;20(01):104-10.
17. Handayani, S. and Isworo, S., 2024. Evaluation of Tuberculosis program implementation in Primary Health Care, Semarang, Indonesia. International Journal of Public Health Asia Pacific, pp.1-11.
18. Handayani, L., 2024. Studi Epidemiologi Tuberkulosis Paru (TB) di Indonesia: Temuan Survey Kesehatan Indonesia (SKI) 2023. Jurnal Kendari Kesehatan Masyarakat, 4(1), pp.59-67.
19. Harahap, D.W.S., Andrajati, R., Sari, S.P. and Handayani, D., 2024. Medication Adherence among Drug-Resistant Tuberculosis (DR-TB) Patients at Universitas Indonesia Hospital. Jurnal Respirologi Indonesia, 44(3), pp.196-200.
20. Harahap, E.C.L., Purwanti, A. and Hardianto, N., 2024. Perbedaan Proporsi Sputum Bakteri Tahan Asam Positif pada Pasien Diabetes Melitus Terkendali dan Tidak Terkendali. Jurnal Laboratorium Khatulistiwa, 8(1), pp.168-180.
21. Harahap K, Sinaga BY, Syarani F, Eyanoer PC. Factors Associated with the Incidence of Pulmonary Tuberculosis in Patients with Type 2 Diabetes Mellitus. Mutiara Medika: Jurnal Kedokteran dan Kesehatan. 2025 Jul 31;25(2):123-31.
22. Hariyanto, S.W., Avidati, H., Ulfah, U., Nurlaily, A.N. and Tejaningrum, K.D., Tuberculosis Screening in Patients with Diabetes Mellitus at the Internal Medicine Clinic of UGM Academic Hospital: Descriptive Study. Academic Hospital Journal, 7(1), p.8.
23. Herman, D., Machmud, R. and Lipoeto, N.I., 2025. Unraveling the Link between Obesity and Tuberculosis: A Systematic Review of the Underlying Mechanisms. Bioscientia Medicina: Journal of Biomedicine and Translational Research, 9(2), pp.6453-6466.
24. Hong, K.J., Wang, T.C. and Tsui, K., 2025. Association of acid-suppressive therapy and tuberculosis: A causal or coincidental link to the infection?. Respiratory Investigation, 63(1), pp.27-32.
25. Houben, R.M., Menzies, N.A., Sumner, T., Huynh, G.H., Arinaminpathy, N., Goldhaber-Fiebert, J.D., Lin, H.H., Wu, C.Y., Mandal, S., Pandey, S. and Suen, S.C., 2016. Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models. The Lancet Global Health, 4(11), pp.e806-e815.
26. Hsu, C.M., Wu, C.J., Chang, C.J., Pan, S.W., Tseng, Y.H., Huang, J.R., Su, W.J., Feng, J.Y. and Chen, Y.M., 2025. Recurrence of tuberculosis and associated risk factors among Non-HIV patients in Taiwan: A retrospective cohort study. Journal of Infection and Public Health, p.102912.
27. Huang CC, Tan Q, Becerra MC, Calderon R, Contreras C, Howard NC, Lecca L, Jimenez J, Madden AE, Yataco R, Galea JT. Impact of Diabetes Mellitus in Tuberculosis (TB) Patients on TB Transmission. Clinical Infectious Diseases. 2026 May 15;82(5):829-40.
28. Huang, F. and Bello, S.T., 2024. Spatiotemporal analysis of regional and age differences in tuberculosis prevalence in mainland China. Tropical Medicine & International Health, 29(9), pp.833-841.
29. Huang, H.L., Cheng, M.H., Lee, M.R., Chien, J.Y., Lu, P.L., Sheu, C.C., Wang, J.Y., Chong, I.W., Yang, J.M. and Huang, W.C., 2025. Prevalence and treatment outcomes of latent tuberculosis infection among older patients with chronic obstructive pulmonary disease in an area with intermediate tuberculosis burden. Emerging Microbes & Infections, 14(1), p.2497302.
30. Huang, H.L., Huang, W.C., Lin, K.D., Liu, S.S., Lee, M.R., Cheng, M.H., Chin, C.S., Lu, P.L., Sheu, C.C., Wang, J.Y. and Lee, I.T., 2021. Completion rate and safety of programmatic screening and treatment for latent tuberculosis infection in elderly patients with poorly controlled diabetic mellitus: a prospective multicenter study. Clinical Infectious Diseases, 73(6), pp.e1252-e1260.
31. Huang, Y.W., Yu, M.C., Lin, C.B., Lee, J.J., Lin, C.J., Chien, S.T., Lee, C.H. and Chiang, C.Y., 2024. Mitigating treatment failure of pulmonary pre-extensively drug-resistant tuberculosis: The role of new and repurposed drugs. Journal of Microbiology, Immunology and Infection, 57(4), pp.617-628.
32. Hung, L.C., Kung, P.T., Tsai, T.H., Tsai, W.C. and Huang, K.H., 2025. Risk Assessment of Tuberculosis in Patients With Chronic Mental Illness and Related Factors: A Population‐Based Cohort Study in Taiwan. The Clinical Respiratory Journal, 19(6), p.e70088.
33. Innes, A.L., Lebrun, V., Hoang, G.L., Martinez, A., Dinh, N., Nguyen, T.T.H., Huynh, T.P., Quach, V.L., Nguyen, T.B., Trieu, V.C. and Tran, N.D.B., 2024. An effective health system approach to end TB: implementing the double X strategy in Vietnam. Global Health: Science and Practice, 12(3).
34. Irnawati, I., Wulan, D. R., Rahmatullah, R., Kartikasari, D., Permadi, Y. W., & Arifin, M. (2026). Environmental housing conditions of tuberculosis patients in a tidal-flooded area: Evidence from one of the world’s second-highest tb-burden countries. BIS Health and Environmental Science, 3, V326012.
35. Iskandar, D., Suwantika, A.A., Pradipta, I.S., Postma, M.J. and van Boven, J.F., 2023. Clinical and economic burden of drug-susceptible tuberculosis in Indonesia: national trends 2017–19. The Lancet Global Health, 11(1), pp.e117-e125.
36. Ismail, Nazir, Harry Moultrie, Judith Mwansa-Kambafwile, Andrew Copas, Alane Izu, Sizulu Moyo, Donald Skinner et al. "Effects of conditional cash transfers and pre-test and post-test tuberculosis counselling on patient outcomes and loss to follow-up across the continuum of care in South Africa: a randomised controlled trial." The Lancet Infectious Diseases (2025).